Infection Range

UrgoClean Ag

UrgoClean Ag is the only anti-biofilm silver dressing that provides complete and continuous cleaning action to the wound. Antimicrobial efficacy you can trust, proven in a real-life study with more than 2,000 patients.2

  • Fast action: from 30 minutes on main strains8
  • Works against bacterial strains resistant to antibiotics (e.g MRSA, VRE)2
  • 99.99% efficacy in just 24h8
  • Restores the healing process1
waiting room

Complete & continuous cleaning action

speech

Polyabsorbant fibres remove slough and exudate1

Clean

bracket

CleansAntimicrobial

bracket

Antibiofilm activity

speech

Combined cleaning and antimicrobial action defeats biofilms and prevent their reattachment2
bracket

Antimicrobial activity

speech

Silver ions provide fast & broad spectrum antimicrobial effeciency2

Kills

EASY TO USE: 2 FORMATS
UrgoClean Ag

Soft adherent pad

Can be cut
can be used under compression
Haemostatic
Cavity wound cut in a spiral
Atraumatic removal
Absorb exudate

Polyabsorbent Fibres

  • Delivers a complete and continuous cleaning action
  • Absorbs exudate1
  • Traps slough and maintains a clean wound, optimising silver efficacy1
  • Disrupts biofilms and prevents their reattachment1
 
TLC-ag technology

TLC-Ag Technology

  • Proven antimicrobial efficacy2
  • Maintains a moist environment
  • Allows pain-free, atraumatic removal1
UrgoTul Silver

Contact layer

Can be cut
can be used under compression
cavity wound
Atraumatic removal

Recommended for wounds with <30% sloughy tissue.

 

TLC-ag technology

TLC-Ag Technology

  • Proven antimicrobial efficacy2
  • Maintains a moist environment
  • Allows pain-free, atraumatic removal1
 
References:

1. Dalac S., Sigal L., Addala A., et al Clinical evaluation of a dressing with poly-absorbent fibres and a silver matrix for managing chronic wounds at risk of infection: a non comparative trial. J Wound Care, Vol 25, No 9, September.

2. Desroche N., Dropet C., Janod P., Guzzo J., Antibacterial properties and reduction of MRSA biofilm with a dressing combining polyabsorbent fibres and a silver matrix. J Wound Care, Vol 25, No 10, October 2016.

3. Lazareth T, Meaume S, Sigal-Grinberg M-L, et al. The role of a Silver Releasing Lipido[1]colloid Contact Layer in Venous Leg Ulcers Presenting Inflammatory Signs Suggesting Heavy Bacterial Colonization: Results of a Randomized Controlled Study. WOUNDS 2008;20(6):158-166.

4. Meaume S, Dissemond J, et al, Evaluation of two fibrous wound dressings for the management of leg ulcers: Results of a European randomized controlled trial (EARTH RCT). J Wound Care , Vol 2, No 3; March 2014, 105-116.

5. Dissemond J, Dietlein M, NeβELER L, Funke L, Scheuermann O, Becker E, Thomassin L, Möller U, Bohbot S, Múnter KC. Use of a TLC-Ag dressing on 2270 patients with wounds at risk or with signs of local infection: an observational study. J Wound Care. 2020,Mar 2;29(3):162-173. doi: 10,12968/jowc2020.29.3.162. PMID: 32160091.

6. UrgoClean Ag data on file.

7. Desroche N, et al. Characterization of the antimicrobial spectrum and anti-biofilm activity of a new silver-containing dressing with poly-absorbent fibres and antimicrobial silver matrix. Poster EWMA May 2016.

8. Desroche N, et al. Evaluation of in vitro anti-biofilm activities of a new poly-absorbent dressing with a silver matrix and a silver-containing CMC dressing. Poster EWMA May 2017.

9. Desroche N, et al. Evaluation of in vitro anti-biofilm activities of two dressings with poly[1]absorbent dressing fibres and a DACC-coated dressing. Poster EWMA 2017.

10. Wounds UK (2021) Best Practice Statement: Use of silver dressings in wound care. Wounds UK, London.

11. Desroche N, et al. Comparison of in vitro anti-biofilm activities of a new poly-absorbent dressing with a silver matrix and a silver-containing CMC dressing. Poster EWMA, May 2017.